CTKB

CTKB

USD

Cytek Biosciences Inc. Common Stock

$3.440-0.080 (-2.273%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$3.520

Máximo

$3.570

Mínimo

$3.415

Volumen

1.30M

Fundamentos de la Empresa

Capitalización de Mercado

435.7M

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

1.07M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $2.37Actual $3.440Máximo $7.63

Noticias Relacionadas

GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th

Ver más
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences with a Equal-Weight and lowers the price target from $9 to $7.

Ver más
Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $7
GlobeNewswire

Cytek Biosciences Reports First Quarter 2025 Financial Results

FREMONT, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), a leading cell analysis solutions company, today reported financial results for the first

Ver más
Cytek Biosciences Reports First Quarter 2025 Financial Results

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.